Leukemia-propagating cells demonstrate distinctive gene expression profiles compared with other cell fractions from patients with de novo Philadelphia chromosome-positive ALL.
Zhao, Hong-Yan; Song, Yang; Cao, Xie-Na; Qin, Ya-Zhen; Lai, Yue-Yun; Jiang, Hao; Jiang, Qian; Huang, Xiao-Jun; Kong, Yuan.
; 97(5): 799-811, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29429020
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options.
Plexin-B2 Mediates Physiologic and Pathologic Functions of Angiogenin.
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease.
[Adverse events of ABL tyrosine kinase inhibitors in chronic myeloid leukemia therapy].
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management.
Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis Simulating Essential Thrombocythemia.
Targeting the SH2-kinase interface in Bcr-Abl inhibits leukemogenesis.
Attacking cancer at its root.
[Molecular analysis of the BCR-ABL1 fusion gene in a chronic myeloid leukemia patient with BCR-ABL1 International Scale-undetectable disease].
[Co-occurrence of t(8;21)(q22;q22) and t(9;22)(q34;q11) in a case with chronic myelogenous leukemia].